Figure 4 from Modeling MRD Changes in Myeloma to Understand Treatment Effects, Predict Outcomes, and Investigate Curative Potential

<p>Time to achievement of CR or better by arm in patients achieving CR or better.</p>

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Walter M. Gregory (14932587) (author)
مؤلفون آخرون:	Thomas J. Prior (21468392) (author), J. Blake Bartlett (21468395) (author), Pieter Sonneveld (21468398) (author), Meletios A. Dimopoulos (13152964) (author), Philippe Moreau (16918404) (author), Saad Usmani (17885498) (author), Thierry Facon (21468401) (author)
منشور في:	2025
الموضوعات:	Cancer Cancer Detection and Diagnosis Clinical Research and Trials Methods and Technology Epidemiology Biomarkers Early detection biomarkers Prognostic biomarkers Biostatistics Clinical Trial Results Phase III clinical trials Hematological Cancers Myelomas Methodology And Modeling
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة